Open AccessHotspots of Aberrant Enhancer Activity in Fibrolamellar Carcinoma Reveal Candidate Oncogenic Pathways and Therapeutic Vulnerabilities
Author(s) -
Timothy A. Dinh,
Ramja Sritharan,
F. Donelson Smith,
Adam B. Francisco,
K. Rosanna,
Rodica P. Bunaciu,
Matt Kanke,
Charles G. Danko,
Andrew P. Massa,
John D. Scott,
Praveen Sethupathy
Publication year - 2020
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2020.03.073
Subject(s) - enhancer , chromatin , biology , cancer research , gene , candidate gene , mapk/erk pathway , viability assay , computational biology , cell , transcription factor , genetics , signal transduction
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom